Planta Med 2011; 77(14): 1605-1609
DOI: 10.1055/s-0030-1270935
Natural Product Chemistry
Original Papers
© Georg Thieme Verlag KG Stuttgart · New York

Four New Carvotanacetone Derivatives from Sphaeranthus ukambensis, Inhibitors of the Ubiquitin-Proteasome Pathway

Isabelle Pouny1 , Stéphane Vispé2 , Laurence Marcourt1 , Christophe Long1 , Isabelle Vandenberghe2 , Yannick Aussagues3 , Roselyne Raux3 , Patrick B. Chalo Mutiso4 , Georges Massiot1 , François Sautel1
  • 1Unité Mixte de Service 2597, Centre National de la Recherche Scientifique (CNRS) – Pierre Fabre, Institut des Sciences et Technologies du Médicament de Toulouse, Toulouse, France
  • 2Centre de Recherche en Oncologie Expérimentale, Institut des Sciences et Technologies du Médicament de Toulouse (ISTMT), Toulouse, France
  • 3Unité Mixte de Service 2646, Centre National de la Recherche Scientifique (CNRS) – Pierre Fabre, Institut des Sciences et Technologies du Médicament de Toulouse (ISTMT), Toulouse, France
  • 4School of Biological Sciences, University of Nairobi, Nairobi, Kenya
Further Information

Publication History

received October 1, 2010 revised February 22, 2011

accepted March 1, 2011

Publication Date:
21 March 2011 (online)

Abstract

Six carvotanacetone derivatives (16), amongst which four new compounds (14), were isolated from the aerial parts of Sphaeranthus ukambensis Vatke & O. Hoffm. The structures of the molecules were elucidated by complementary spectroscopic methods, and their biological properties were investigated using human DLD-1 colon cancer cells engineered to stably express a 4 ubiquitin-luciferase (4 Ub-Luc) reporter protein. Five of the isolated carvotanacetone derivatives (26) were found to inhibit the proliferation of the colon cancer cells and interfere with the ubiquitin-proteasome pathway, with potencies in a micromolar range.

Supporting information available online at http://www.thieme-connect.de/ejournals/toc/plantamedica

References

  • 1 Ragasa C Y, Tsai P W, Galvez C T, Shen C-C. New carvotanacetone derivatives from Sphaeranthus africanus.  Planta Med. 2010;  76 146-151
  • 2 Jakupovic J, Grenz M, Bohlmann F, Mungai G M. Carvotacetone derivatives and eudesman-12, 6β-olides from Sphaeranthus species.  Phytochemistry. 1990;  29 1213-1217
  • 3 Zdero C, Bohlmann F, Mungai G M. Carvotacetone derivatives and other constituents from representatives of the Sphaeranthus group.  Phytochemistry. 1991;  30 3297-3303
  • 4 Eid F, El-Dahmy S. Carvotanacetone derivatives from Sphaeranthus suaveolens.  Pharmazie. 1988;  43 347-348
  • 5 Ahmed A A, Mahmoud A A. Carvotacetone derivatives from the Egyptian plant Sphaeranthus suaveolens.  Phytochemistry. 1997;  45 533-535
  • 6 Beentje H J ed.. Flora of tropical East Africa, Compositae (Part 2). Kew; Royal Botanic Gardens 2002: 370-391
  • 7 Kokwaro J O. Medicinal plants of East Africa. 2nd edition. Nairobi; Kenya Literature Bureau 1993: 82-83
  • 8 Gradé J T, Tabuti J R S, Van Damme P. Ethnoveterinary knowledge in pastoral Karamoja, Uganda.  J Ethnopharmacol. 2009;  122 273-293
  • 9 Vandenberghe I, Créancier L, Vispé S, Annereau J P, Barret J M, Pouny I, Samson A, Aussagues Y, Massiot G, Ausseil F, Bailly C, Kruczynski A. Physalin B, a novel inhibitor of the ubiquitin-proteasome pathway, triggers NOXA-associated apoptosis.  Biochem Pharmacol. 2008;  76 453-462
  • 10 Testa U. Proteasome inhibitors in cancer therapy.  Curr Drug Targets. 2009;  10 968-981

Dr. Isabelle Pouny

Unité de Service et de Recherche 3388
Centre National de la Recherche Scientifique (CNRS) – Pierre Fabre

3 Avenue Hubert Curien

BP13562

31035 Toulouse Cedex 01

France

Phone: +33 5 34 50 62 07

Fax: +33 5 34 50 32 07

Email: isabelle.pouny@pierre-fabre.com

>